BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23196063)

  • 1. HER2 overexpression-mediated inflammatory signaling enhances mammosphere formation through up-regulation of aryl hydrocarbon receptor transcription.
    Zhao S; Ohara S; Kanno Y; Midorikawa Y; Nakayama M; Makimura M; Park Y; Inouye Y
    Cancer Lett; 2013 Mar; 330(1):41-8. PubMed ID: 23196063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the aryl hydrocarbon receptor represses mammosphere formation in MCF-7 cells.
    Zhao S; Kanno Y; Nakayama M; Makimura M; Ohara S; Inouye Y
    Cancer Lett; 2012 Apr; 317(2):192-8. PubMed ID: 22123295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.
    Zhang F; Song C; Ma Y; Tang L; Xu Y; Wang H
    Int J Mol Med; 2011 Sep; 28(3):365-71. PubMed ID: 21573501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.
    Grudzien P; Lo S; Albain KS; Robinson P; Rajan P; Strack PR; Golde TE; Miele L; Foreman KE
    Anticancer Res; 2010 Oct; 30(10):3853-67. PubMed ID: 21036696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heregulin-induced cell migration is promoted by aryl hydrocarbon receptor in HER2-overexpressing breast cancer cells.
    Yamashita N; Saito N; Zhao S; Terai K; Hiruta N; Park Y; Bujo H; Nemoto K; Kanno Y
    Exp Cell Res; 2018 May; 366(1):34-40. PubMed ID: 29501698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation.
    Glinka Y; Mohammed N; Subramaniam V; Jothy S; Prud'homme GJ
    Biochem Biophys Res Commun; 2012 Sep; 425(4):775-80. PubMed ID: 22885184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible Involvement of the Upregulation of ΔNp63 Expression Mediated by HER2-Activated Aryl Hydrocarbon Receptor in Mammosphere Maintenance.
    Kanno Y; Saito N; Yamashita N; Ota K; Shizu R; Hosaka T; Nemoto K; Yoshinari K
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the aryl hydrocarbon receptor by 3-methylcholanthrene, but not by indirubin, suppresses mammosphere formation via downregulation of CDC20 expression in breast cancer cells.
    Yamashita N; Yoshizuka A; Kase A; Ozawa M; Taga C; Sanada N; Kanno Y; Nemoto K; Kizu R
    Biochem Biophys Res Commun; 2021 Sep; 570():131-136. PubMed ID: 34280616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
    Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
    Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR).
    Wong PS; Li W; Vogel CF; Matsumura F
    BMC Cancer; 2009 Jul; 9():234. PubMed ID: 19604390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.
    Lattrich C; Juhasz-Boess I; Ortmann O; Treeck O
    Oncol Rep; 2008 Mar; 19(3):811-7. PubMed ID: 18288420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells.
    Shi M; Liu D; Duan H; Qian L; Wang L; Niu L; Zhang H; Yong Z; Gong Z; Song L; Yu M; Hu M; Xia Q; Shen B; Guo N
    Breast Cancer Res Treat; 2011 Jan; 125(2):351-62. PubMed ID: 20237834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.
    Stanford EA; Wang Z; Novikov O; Mulas F; Landesman-Bollag E; Monti S; Smith BW; Seldin DC; Murphy GJ; Sherr DH
    BMC Biol; 2016 Mar; 14():20. PubMed ID: 26984638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Differential Selectivity of Aryl Hydrocarbon Receptor (AHR) Agonists towards AHR-Dependent Suppression of Mammosphere Formation and Gene Transcription in Human Breast Cancer Cells.
    Saito N; Kanno Y; Yamashita N; Degawa M; Yoshinari K; Nemoto K
    Biol Pharm Bull; 2021; 44(4):571-578. PubMed ID: 33790107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
    Asanuma H; Torigoe T; Kamiguchi K; Hirohashi Y; Ohmura T; Hirata K; Sato M; Sato N
    Cancer Res; 2005 Dec; 65(23):11018-25. PubMed ID: 16322251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of osteopontin expression by aryl hydrocarbon receptor via both ligand-dependent and ligand-independent pathways in lung cancer.
    Chuang CY; Chang H; Lin P; Sun SJ; Chen PH; Lin YY; Sheu GT; Ko JL; Hsu SL; Chang JT
    Gene; 2012 Jan; 492(1):262-9. PubMed ID: 22037483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.
    Singh JK; Farnie G; Bundred NJ; Simões BM; Shergill A; Landberg G; Howell SJ; Clarke RB
    Clin Cancer Res; 2013 Feb; 19(3):643-56. PubMed ID: 23149820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture.
    Rodríguez CE; Berardi DE; Abrigo M; Todaro LB; Bal de Kier Joffé ED; Fiszman GL
    J Cell Biochem; 2018 Feb; 119(2):1381-1391. PubMed ID: 28722778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity.
    Brantley E; Callero MA; Berardi DE; Campbell P; Rowland L; Zylstra D; Amis L; Yee M; Simian M; Todaro L; Loaiza-Perez AI; Soto U
    Cancer Lett; 2016 Jun; 376(1):53-61. PubMed ID: 26996297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2 regulatory control of angiopoietin-2 in breast cancer.
    Carter WB; Ward MD
    Surgery; 2000 Aug; 128(2):153-8. PubMed ID: 10922985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.